🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is designed as a 3-year, multicenter, open-label study evaluatin...
Status
Terminated
Location
Research Site
Start Date
2021-07-15
Trial ID
NCT04931667
Treatments Being Tested
This phase 3 study is a multicenter, randomized, double-blind, placebo-cont...
Status
Completed
Location
Research Site
Start Date
2020-05-26
Trial ID
NCT04385303
Treatments Being Tested
The purpose of this study is to assess the efficacy, safety, and tolerabili...
Status
Completed
Location
Research Site
Start Date
2015-09-09
Trial ID
NCT02536833
The purpose of this study is to find the optimal dose of SM04690 that can b...
Status
Completed
Location
Multiple Locations
Start Date
2014-03
Trial ID
NCT02095548
Treatments Being Tested
Study OA-07 was a randomized, double-blind, placebo-controlled, Phase 3, mu...
Status
Terminated
Location
Research Site
Start Date
2020-08-25
Trial ID
NCT04520607
Treatments Being Tested
This phase 3 study is a multicenter, randomized, double-blind, placebo-cont...
Status
Completed
Location
Tucson Orthopaedic Institute
Start Date
2022-11-18
Trial ID
NCT05603754
Treatments Being Tested
This phase 2 study is a placebo-controlled, double-blind, parallel group st...
Status
Completed
Location
Research Site
Start Date
2017-04-24
Trial ID
NCT03122860
This study will be an open-label, parallel-arm study to determine if a prio...
Status
Completed
Location
Research Site
Start Date
2020-10-13
Trial ID
NCT04598542
Treatments Being Tested
The primary purpose of this phase 2, placebo-controlled, double-blind, para...
Status
Completed
Location
Research Site
Start Date
2018-11-28
Trial ID
NCT03727022
SM04690-DDD-01 is a Phase 1, open-label, dose escalation study. SM04690 Inj...
Status
Terminated
Location
Research Site
Start Date
2017-07-26
Trial ID
NCT03246399
Treatments Being Tested